Abbvie Inc
NYSE: ABBV
$193.83
+$1.49 (+0.8%)
Real Time Data Delayed 15 Min.
ABBV Stock Chart and Intraday Price
ABBV Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 316,039.17M USD |
| Shares Outstanding | 1,766,470,000 |
ABBV Articles
These five Dividend Aristocrats have the least negligible impact from the tariffs and are ideal for passive income investors.
Published:
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
Published:
If you want a way to combine steady income, stability, and diversification, an exchange-traded fund (ETF) can deliver all three. The iShares Core High ETF (NYSEARCA:HDV) is worth looking into since...
Published:
Yesterday’s wild rally in the stock market where $5.5 trillion in value following President Trump hitting a 90-day pause on his tariffs, exemplifies the dramatic swings investors have experienced...
Published:
Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios. About 20% of the S&P 500 stocks hit a 52-week low before the tariff...
Published:
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Published:
In the 2020s, there are plenty of yield-focused exchange traded funds (ETFs) to choose from, and they’re not all created equal. Two popular dividend funds in particular — the Schwab U.S. Dividend...
Published:
Forget the old adage “it takes money to make money.” In the stock market, even a measly $500 can kickstart a fortune. Time, not a fat wallet, is the real MVP here. With the right picks, that...
Published:
If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. Denner is the CEO and CIO of Sarissa Capital Management, a Greenwich-based...
Published:
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
One solid idea for growth and income investors who want to stay invested but shift to a more balanced approach is to look at the incredible Dividend Kings.
Published:
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Published:
Live Updates Live Coverage Has Ended Deep Dive into ABBV's Earnings Call 11:53 am by Rich Duprey Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq...
Published:
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Published:
Last Updated:
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
